BOULDER, Colo.–(BUSINESS WIRE)–Havah Therapeutics, a clinical stage biopharmaceutical company developing innovative, proprietary hormonal implant therapies for prevention and treatment of breast cancers, today announced that the company will present real world patient data at the upcoming RiseUp for Breast Cancer Conference. The presentation will demonstrate the therapeutic potential of Havah’s novel combination implant therapy – of testosterone plus the aromatase inhibitor anastrozole – in a
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
